Intravenous Immunoglobulin Market Size, Share, Trends, Industry Report 2024-34
3 min readMarket Overview:
The intravenous immunoglobulin market reached a value of US$ 12.7 Billion in 2023 and expected to reach US$ 23.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.76% during 2024-2034. The intravenous immunoglobulin market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the intravenous immunoglobulin market.
Request for a Sample of this Report: https://www.imarcgroup.com/intravenous-immunoglobulin-market/requestsample
Intravenous Immunoglobulin Market Trends:
- Definition: Intravenous immunoglobulin (IVIG) is a pooled antibody and biological agent derived from human blood plasma, used in various therapeutic applications.
- Market Growth Drivers:
- Rising Prevalence of Autoimmune Diseases:
- Increased cases of autoimmune diseases, including primary immunodeficiency disorders (PID), chronic inflammatory demyelinating polyneuropathy (CIDP), and immune thrombocytopenic purpura (ITP).
- Growing demand for IVIG therapies as these conditions become more widely recognized and diagnosed.
- Aging Population:
- Elderly individuals are more prone to immunodeficiencies and autoimmune disorders, driving demand for IVIG treatments.
- Rising Prevalence of Autoimmune Diseases:
- Enhancements in Plasma Supply:
- Advanced Collection Techniques:
- Technological advancements in plasma collection and expansion of plasma donation centers support the steady supply of immunoglobulin.
- Advanced Collection Techniques:
- Research and Development (R&D) in IVIG:
- Focus on enhancing the safety and efficacy of IVIG products.
- Exploration of new therapeutic applications to expand IVIG use cases.
- Shift Towards Home Healthcare:
- Increased adoption of self-administration with subcutaneous immunoglobulin (SCIG) options, offering more convenient home-based treatment.
- Innovative IVIG Formulations and Delivery Methods:
- Introduction of newer, more efficient formulations to improve patient compliance and treatment outcomes.
- Future Growth Outlook:
- Expanding treatment indications and improved therapeutic options are expected to fuel intravenous immunoglobulin market growth in the coming years.
Countries Covered:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country:
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the intravenous immunoglobulin market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the intravenous immunoglobulin market
- Reimbursement scenario in the market
- In-market and pipeline drugs
This report also provides a detailed analysis of the current intravenous immunoglobulin market and late-stage pipeline drugs.
In-Market Drugs:
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Drug uptake and market performance
Competitive Landscape:
The competitive landscape of the intravenous immunoglobulin market has been studied in the report with the detailed profiles of the key players operating in the market.
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7461&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145